<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01157806</url>
  </required_header>
  <id_info>
    <org_study_id>0109</org_study_id>
    <nct_id>NCT01157806</nct_id>
  </id_info>
  <brief_title>Palliative Radiochemotherapy Against Palliative Surgery in Stage IV Rectal Cancer With Unresectable Metastases</brief_title>
  <official_title>Palliative Radiotherapy Followed by Chemotherapy Against Palliative Surgery in Patients With Rectal Cancer With Unresectable Synchronous Distant Metastases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maria Sklodowska-Curie Institute - Oncology Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maria Sklodowska-Curie Institute - Oncology Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Short course palliative radiotherapy (5x5Gy)to the pelvis in patients with symptomatic rectal
      tumours and with unresectable metastases may prevent palliative surgery with a good
      palliative outcome.The consolidating chemotherapy of XELOX may increase the efficacy of
      irradiation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with symptomatic rectal cancer and unresectable metastases receive 25 Gy in 5
      fractions of 5 Gy over 5 days to the pelvis and XELOX consolidating chemotherapy after one
      week. Investigators arbitrarily assumed that palliative radiotherapy to the pelvis can
      replace the immediate surgery if at least 30% of patients would avoid delayed surgery until
      the end of their lives, or for at least 18 months in the case of long-term survival.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2010</start_date>
  <completion_date type="Anticipated">June 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2010</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>percentage of patients not requiring palliative surgery during the follow-up</measure>
    <time_frame>every three months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The rate of early toxicity of radiotherapy according to the NCI CTCAE (version 3.0)</measure>
    <time_frame>3 months</time_frame>
    <description>Assess prospectively by filling forms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Palliative effect of radiotherapy</measure>
    <time_frame>every three months</time_frame>
    <description>Assessment of radiochemotherpy effectivenes by patients using questionaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time from palliative radiotherapy to delayed palliative surgery</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determination of prognostic factors indicating the need for immediate palliative surgery.</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Rectal Cancer</condition>
  <arm_group>
    <arm_group_label>radiochemotherapy instead of surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>short course of palliative radiotherapy</intervention_name>
    <description>5x5 Gy + XELOX 7 days after radiotherapy</description>
    <arm_group_label>radiochemotherapy instead of surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histologically confirmed primary carcinoma of the rectum (Lower border of tumour â‰¤ 10
             cm from anal verge)

          -  Occurrence of subjective clinical symptoms of the primary tumor

          -  Non-resectable synchronous distant metastases. The decision of non-resectable
             metastases will be made at multidisciplinary clinical meetings.

        Exclusion Criteria:

          -  Obstruction of the gastrointestinal tract

          -  Previously constructed stoma

          -  prior radiotherapy of the pelvis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Krzysztof Bujko, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>M. Sklodowska-Curie Memorial Cancer Centre Warsaw, Poland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wojciech Michalski, M. S.</last_name>
    <phone>+48226433909</phone>
    <email>W.Michalski@coi.waw.pl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>: Krzysztof Bujko, Prof.</last_name>
    <phone>+48226439287</phone>
    <email>bujko@coi.waw.pl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>M. Sklodowska-Curie Memorial Cancer Centre</name>
      <address>
        <city>Warsaw</city>
        <zip>02-781</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krzysztof Bujko, Prof.</last_name>
      <phone>+48226439287</phone>
      <email>bujko@coi.waw.pl</email>
    </contact>
    <investigator>
      <last_name>Krzysztof Bujko, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>February 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 6, 2010</study_first_submitted>
  <study_first_submitted_qc>July 6, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 7, 2010</study_first_posted>
  <last_update_submitted>February 14, 2011</last_update_submitted>
  <last_update_submitted_qc>February 14, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 16, 2011</last_update_posted>
  <responsible_party>
    <name_title>Prof. Krzysztof Bujko</name_title>
    <organization>Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology in Warsaw</organization>
  </responsible_party>
  <keyword>rectal cancer</keyword>
  <keyword>unresectable synchronous metastases</keyword>
  <keyword>pelvic radiochemotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

